“Every time I had to pay $50, it was adding up, but there was no option”: A qualitative study with parents and primary caregivers in Australia on barriers to timely childhood vaccination

COVID-19 vaccine adverse events in indigenous communities in Northwest Territories, Canada

Predictors of willingness to use an HIV vaccine among gay, bisexual, and other men who have sex with men, and transgender and non-binary persons: evaluating the role of vaccine confidence, altruistic motivations, social concerns, and conspiracy beliefs

Estimating the cost of reaching zero-dose children in hard-to-reach areas of Ethiopia: the case of periodic intensification of routine immunization strategy

Association between village coverage of 13-valent pneumococcal conjugate vaccine and vaccine-type pneumococcal carriage among children aged 0–59 months with pneumonia in Papua New Guinea: an observational study

Impact and cost-effectiveness of maternal vaccine and short and long-acting monoclonal antibodies against respiratory syncytial virus among children in Japan: A modeling study

“Every time I had to pay $50, it was adding up, but there was no option”: A qualitative study with parents and primary caregivers in Australia on barriers to timely childhood vaccination

COVID-19 vaccine adverse events in indigenous communities in Northwest Territories, Canada

Predictors of willingness to use an HIV vaccine among gay, bisexual, and other men who have sex with men, and transgender and non-binary persons: evaluating the role of vaccine confidence, altruistic motivations, social concerns, and conspiracy beliefs

Estimating the cost of reaching zero-dose children in hard-to-reach areas of Ethiopia: the case of periodic intensification of routine immunization strategy

Association between village coverage of 13-valent pneumococcal conjugate vaccine and vaccine-type pneumococcal carriage among children aged 0–59 months with pneumonia in Papua New Guinea: an observational study

Impact and cost-effectiveness of maternal vaccine and short and long-acting monoclonal antibodies against respiratory syncytial virus among children in Japan: A modeling study